Epithelial defect in prostates of Stat5a-null mice.
The transcription factor Stat5a critically mediates prolactin (PRL)-induced mammary gland development and lactogenesis. PRL also stimulates growth and differentiation of prostate tissue. Specifically, hyperprolactinemia gives rise to prostate hyperplasia, and prostate size is reduced in PRL-deficient mice. We therefore investigated the importance of Stat5a for prostate development and function by examining Stat5a-null mice. The absence of Stat5a in mice was associated with a distinct prostate morphology characterized by an increased prevalence of local disorganization within acinar epithelium of ventral prostates. Affected acini were typically filled with desquamated, granular epithelial cells that had become embedded in dense, coagulated secretory material. These features were reminiscent of acinar cyst formation and degeneration frequently observed in human benign prostate hyperplasia, however, cystic changes in prostate acini of Stat5a-deficient mice were not associated with increased prostate size or morphologic hallmarks of epithelial hyperplasia. Instead, immunohistochemistry of the prostate-specific secretory marker, probasin, suggested that hypersecretory function of the epithelium could underlie local congestion and cyst formation in prostates of Stat5a-null mice. Serum testosterone and PRL levels were normal in Stat5a knockout mice, but prostate PRL receptor expression was reduced as determined by immunohistochemistry. Expression levels or activation states of other PRL signal transduction proteins, including Stat5b, Stat3, Stat1, ERK1, and ERK2 were not altered. The present study offers the first evidence for a direct role of Stat5a in the maintenance of normal tissue architecture and function of the mouse prostate.
Nevalainen
M T
MT
Department of Pathology, Uniformed Services University of the Health Sciences, and National Institutes of Diabetes and Kidney Diseases, National Institutes of Health, Bethesda, Maryland, USA.
Ahonen
T J
TJ
Yamashita
H
H
Chandrashekar
V
V
Bartke
A
A
Grimley
P M
PM
Robinson
G W
GW
Hennighausen
L
L
Rui
H
H
D000818:Animals; D017209:Apoptosis; D002455:Cell Division; D004268:DNA-Binding Proteins / Q000172:deficiency* / Q000235:genetics / Q000378:metabolism; D004847:Epithelial Cells / Q000473:pathology / Q000502:physiology; D004848:Epithelium / Q000378:metabolism / Q000473:pathology; D008297:Male; D051379:Mice; D018345:Mice, Knockout / Q000235:genetics; D008894:Milk Proteins; D011388:Prolactin / Q000097:blood / Q000502:physiology; D011467:Prostate / Q000378:metabolism / Q000473:pathology* / Q000503:physiopathology; D011469:Prostatic Diseases / Q000209:etiology* / Q000235:genetics / Q000378:metabolism / Q000473:pathology*; D011981:Receptors, Prolactin / Q000378:metabolism; D012016:Reference Values; D050799:STAT5 Transcription Factor; D015398:Signal Transduction; D013739:Testosterone / Q000097:blood; D015534:Trans-Activators / Q000172:deficiency* / Q000235:genetics / Q000378:metabolism
D004268:DNA-Binding Proteins; D008894:Milk Proteins; D011981:Receptors, Prolactin; D050799:STAT5 Transcription Factor; C494093:Stat5a protein, mouse; C494096:Stat5b protein, mouse; D015534:Trans-Activators; D013739:Testosterone; D011388:Prolactin